Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Kjeldgaard Vistisen, Kirsten
23  Ergebnisse:
Personensuche X
?
1

Efficacy and safety of regorafenib in the treatment of meta..:

Røed Skårderud, Maria ; Polk, Anne ; Kjeldgaard Vistisen, Kirsten..
Cancer Treatment Reviews.  62 (2018)  - p. 61-73 , 2018
Link: https://doi.org/10.1016/..
 
?
2

The effect of geriatric intervention in frail older patient..:

Lund, Cecilia Margareta ; Vistisen, Kirsten Kjeldgaard ; Olsen, Anne Pries...
British Journal of Cancer.  124 (2021)  12 - p. 1949-1958 , 2021
Link: https://doi.org/10.1038/..
 
?
3

Geriatric assessment and intervention in older vulnerable p..:

Dolin, Troels G. ; Mikkelsen, Marta ; Jakobsen, Henrik L....
BMC Geriatrics.  21 (2021)  1 - p. , 2021
Link: https://doi.org/10.1186/..
 
?
4

Myocardial Ischemia Induced by 5-Fluorouracil: A Prospectiv..:

Dyhl-Polk, Anne ; Schou, Morten ; Vistisen, Kirsten K....
The Oncologist.  26 (2020)  3 - p. e403-e413 , 2020
Link: https://doi.org/10.1002/..
 
?
5

Capecitabine and Oxaliplatin Before, During, and After Radi..:

Larsen, Finn Ole ; Markussen, Alice ; Jensen, Benny V....
Clinical Colorectal Cancer.  16 (2017)  2 - p. e7-e14 , 2017
Link: https://doi.org/10.1016/..
 
?
6

Physical exercise program to older frail patients receiving..:

Olsen, Anne Pries ; Vinther, Anders ; Ragle, Anne-Mette...
Journal of Geriatric Oncology.  14 (2023)  1 - p. 101382 , 2023
Link: https://doi.org/10.1016/..
 
?
7

Interval Walking Improves Glycemic Control and Body Composi..:

Christensen, Jesper F ; Sundberg, Anna ; Osterkamp, Jens...
The Journal of Clinical Endocrinology & Metabolism.  104 (2019)  9 - p. 3701-3712 , 2019
Link: https://doi.org/10.1210/..
 
?
8

The "Interval Walking in Colorectal Cancer" (I-WALK-CRC) st..:

Banck-Petersen, Anna ; Olsen, Cecilie K. ; Djurhuus, Sissal S....
Contemporary Clinical Trials Communications.  9 (2018)  - p. 143-150 , 2018
Link: https://doi.org/10.1016/..
 
?
9

Incidence and risk factors for capecitabine-induced symptom..:

Polk, Anne ; Shahmarvand, Nahid ; Vistisen, Kirsten...
BMJ Open.  6 (2016)  10 - p. e012798 , 2016
Link: https://doi.org/10.1136/..
 
?
10

Maintenance Therapy With Cetuximab Every Second Week in the..:

Pfeiffer, Per ; Sorbye, Hafdan ; Qvortrup, Camilla...
Clinical Colorectal Cancer.  14 (2015)  3 - p. 170-176 , 2015
Link: https://doi.org/10.1016/..
 
?
11

A systematic review of the pathophysiology of 5-fluorouraci..:

Polk, Anne ; Vistisen, Kirsten ; Vaage-Nilsen, Merete.
BMC Pharmacology and Toxicology.  15 (2014)  1 - p. , 2014
Link: https://doi.org/10.1186/..
 
?
12

Cardiotoxicity in cancer patients treated with 5-fluorourac..:

Polk, Anne ; Vaage-Nilsen, Merete ; Vistisen, Kirsten.
Cancer Treatment Reviews.  39 (2013)  8 - p. 974-984 , 2013
Link: https://doi.org/10.1016/..
 
?
13

Effect of a multimodal high intensity exercise intervention..:

Adamsen, Lis ; Quist, Morten ; Andersen, Christina...
BMJ: British Medical Journal.  339 (2009)  7726 - p. 895-899 , 2009
Link: https://www.jstor.org/st..
 
?
14

Increased urinary excretion of 8-oxo-2′-deoxyguanosine, a b..:

Loft, Steffen ; Poulsen, Henrik Enghusen ; Vistisen, Kirsten.
Mutation Research/Genetic Toxicology and Environmental Mutagenesis.  441 (1999)  1 - p. 11-19 , 1999
Link: https://doi.org/10.1016/..
 
?
15

Oxidative DNA damagein vivo: Relationship to age, plasma an..:

Poulsen, Henrik E. ; Loft, Steffen ; Prieme, Helene...
Free Radical Research.  29 (1998)  6 - p. 565-571 , 1998
Link: https://doi.org/10.1080/..
 
1-15